Moderna Announces Supply Agreement With Peru For 20M Doses Of COVID-19 Vaccine
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the government of Peru for 20 million doses of Moderna's
Moderna And Nvidia Lead The Nasdaq-100
U.S. indices were trading higher and continued to gain as investors weigh Wednesday's Fed decision to keep rates unchanged. Markets also rebounded following recent weakness driven by China volatility.
CNBC Pharma Reporter Meg Tirrell Tweets ‘FDA notes at CDC advisory committee meeting that it has a Moderna submission for #covid19 vaccine booster, and “we are working diligently to get that completed.”‘
https://twitter.com/megtirrell/status/1441111507182370824
Why Moderna Shares Are Rising
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 3.8% at $457.32 amid strength in vaccine names. FDA authorization of a booster shot from competitors BioNTech and Pfizer has possibly lifted sector sentiment as well.
Moderna Sponsored Study Titled ‘Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients’ Posted To ClinicalTrials.gov; Study Is Recruiting
https://clinicaltrials.gov/ct2/show/NCT05054218